To examine if AML cells change their immunogenicity during serial transplantations in immunologically normal mice, we generated new AML cells by transducing MLL-AF9 into mouse bone marrow progenitors and examined their immunogenic phenotypes over time (Fig. 6a). This evidence concerns the gene KMT2A and acute myeloid leukemia.